.png)
Call for Abstracts
The National Cannabis Research Conference (NCRC), hosted by the Institute of Cannabis Research and in conjunction with the National Interdisciplinary Cannabis Symposium, is an excellent opportunity to share groundbreaking work with a diverse audience of researchers, healthcare professionals, policymakers, legal, and industry leaders who share a commitment to advancing cannabis and hemp research. We look to researchers in this space to propose timely session topics and help guide the development of the conference program. We welcome proposals on a range of cannabis, hemp, and legal-related topics (see the complete list below).
ABSTRACT SUBMISSION GUIDELINES
ABSTRACT SUBMISSION DEADLINE - MAY 4, 2026
For conference abstracts centered on public policy, regulations, and laws affecting cannabis policy and research, but are not traditional research presentations, the standard Methods, Results, and Discussion structure can be adapted to include a clear statement about the talk, challenges that will be addressed, key stakeholders, influential factors, and proposed strategies or solutions for addressing the identified challenges.
TRIAL REGISTRATION:
If your presentation reports the results of a healthcare intervention on human participants, it must be registered in an appropriate review board, and the registration number (IRB Protocol #) and date of registration should be included at the time of abstract submission. If the presentation includes results involving human participants but is IRB Exempt, please select this option when submitting the abstract.
Use of Vertebrate Animals: If your presentation reports the results of research that includes the use of vertebrate animals, it must be registered in an appropriate review board, and the registration number (IACUC Protocol #) and date of registration should be included along with the abstract at submission.
Clinical Trials.gov #: If your presentation data is from a clinical trial, the trial needs to be registered with clinicaltrials.gov, and the 8-digit National Clinical Trials (NCT) number should be provided at the time of abstract submission.
CONFLICT OF INTEREST:
Authors should disclose any potential conflicts of interest at the time of abstract submission. This includes any financial or non-financial interests that could be perceived as competing.
The Conference Research Abstract should not exceed 350 words.
Please minimize using abbreviations and do not cite references in the abstract. Abstracts should not include any figures or tables. Reports of randomized controlled trials should follow the CONSORT extension for abstracts.
A RESEARCH ABSTRACT must include the following six (6) components, including the subtitles:
-
Title,
-
Background,
-
Methods,
-
Results
-
Discussion
-
Conclusions
TITLE:
A concise and descriptive title
BACKGROUND:
Explain the context and WHY this research is significant.
METHODS (if applicable):
How the study was performed and the statistical tests used
RESULTS & DISCUSSION (if applicable):
The key study results and findings
CONCLUSIONS:
A summary and potential implications.
A NON-RESEARCH ABSTRACT, such as a commentary or perspective, must include a clear summary of the planned presentation, including the following five (5) components:
-
Title
-
Background,
-
Methods (if applicable),
-
Commentary or Perspective,
-
Conclusion
TITLE:
A concise and descriptive title.
BACKGROUND:
Explain the context and WHY this analysis is significant.
METHODS (if applicable):
How the study was performed and the statistical tests used
COMMENTARY or PERSPECTIVE:
Analysis, interpretation, or discussion of topic
CONCLUSIONS:
A summary and potential implications.
